Revolutionary Advances in Medicine: Moderna’s Successful Trials of RSV Vaccine and Innovative Cancer Immunotherapy Unveiled
Moderna has recently announced the results of their phase 3 trials for two mRNA vaccines, namely mRNA-1345, a vaccine targeting the respiratory syncytial virus (RSV), and mRNA-4157, an individualized neoantigen...